Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier
WebMD

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine
WebMD

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion
    WebMD

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community
    WebMD

    Community

    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Depression Health Center

Font Size
A
A
A

FDA OKs Abilify for Depression

Antipsychotic Drug Approved for Use in Addition to Antidepressants for Treating Depression
By
WebMD Health News
Reviewed by Louise Chang, MD

Nov. 20, 2007 -- The FDA has approved the antipsychotic drug Abilify for treatment of depression when used along with antidepressants.

Abilify isn't a new drug; it was first approved five years ago.

But it's the first drug approved by the FDA as an addition to antidepressants for adults with major depressive disorder, according to Otsuka Pharmaceutical Co. and Bristol-Myers Squibb.

Abilify was discovered by Otsuka Pharmaceutical Company, which partners with Bristol-Myers Squibb to sell Abilify in the U.S. and Europe.

In a news release, the drug companies report that the FDA's latest approval for Abilify was based on two studies that each lasted for six weeks.

Together, the studies included 743 depressed adults whose depression hadn't lifted despite the fact that they were taking antidepressants.

All of the patients kept taking antidepressants during the study. They also took Abilify or a placebo pill, without knowing which was which.

Before-and-after surveys show that the patients taking Abilify got more depression relief than those taking the placebo.

In those studies, Abilify's most common side effects were fidgeting, restlessness, insomnia, constipation, fatigue, and blurred vision.

Earlier this month, the FDA approved Abilify to treat schizophrenia in teens aged 13-17. But Abilify isn't approved to treat depression in children.

Today on WebMD

contemplation
Differences between feeling depressed and feeling blue.
jk rowling
Famous people who've struggled with persistent sadness.
 
depressed man sitting on hallway floor
Learn the truth about this serious illness.
Sad woman looking out of the window
Tips to stay the treatment course.
 
unhappy teen boy
Health Check
jk rowling
Slideshow
 
Pills with smiley faces
Article
Teen girl huddled outside house
Article
 
Depressed man sitting in hospital hallway
Article
antidepressants slideshow
Article
 
pill bottle
Article
Winding path
Article